Warnex Signs Agreement for the Acquisition of PRO-DNA Diagnostic Laboratory
News Apr 28, 2006
The purchase price will be approximately $2 million, which is divided into $1.2 million in cash, approximately $200,000 to $300,000 in working capital adjustments and $500,000 payable in common shares of Warnex.
The common shares are subject to milestones that may be achieved in the 25 months following the closing date of the transaction and are also subject to a statutory hold period of 4 months from the date of issue.
The transaction is subject to usual conditions, namely, the conclusion of all related agreements and the relevant regulatory authorizations, and is expected to close within the next month.
"The acquisition of PRO-DNA will mark our entry into the field of human genetics testing and pharmacogenomics," said Mark Busgang, President and CEO of Warnex.
"This is part of our long term vision of becoming a service provider that offers state-of-the-art technology not only in direct-to-patient healthcare but also as part of the broader clinical trial industry."
PRO-DNA had annual revenue of $870,000 in its last fiscal year and is expected to be immediately accretive to earnings. It will operate as a division of Warnex Medical Laboratories and it will be relocated in the Warnex building in Laval, Quebec.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018